Stock Market Fluctuation: Oracle and Nvidia Rise, Kenvue Takes a Hit

## Overview Oracle Corporation is a global leader in enterprise software and cloud computing, renowned for its database management systems and comprehensive suite of business applications. Headquartered in Austin, Texas, Oracle serves organizations of all sizes across industries, providing the technological backbone for operations, analytics, and digital transformation[6]. Its mission centers on helping people see data in new ways, discover insights, and unlock possibilities through innovation[5]. ## History and Evolution Founded in 1977 by Larry Ellison, Bob Miner, and Ed Oates as Software Development Laboratories in Santa Clara, California, the company released its flagship Oracle Database in 1979—a pioneering relational database management system that revolutionized data storage and access[2][5]. Renamed Oracle Corporation in 1982, the company grew rapidly, going public in 1986 and expanding globally[2][5]. By the 1990s, Oracle was recognized as the world’s largest database management company, with innovations like Oracle7 cementing its industry leadership[5]. Oracle’s expansion into enterprise applications—such as ERP, CRM, HCM, and supply chain management—solidified its role as a one-stop provider for business software[6]. The 2010s marked a strategic pivot to cloud computing, with the launch of Fusion Cloud applications and the aggressive build-out of data centers to support its public cloud offerings[2]. ## Key Achievements Oracle’s achievements include the development of the first commercially viable relational database, the creation of integrated enterprise software suites, and the consolidation of its own global operations using its technology, saving over $1 billion[5]. The company’s cloud infrastructure now supports more than a thousand government customers across at least 60 data centers, and it offers over 100 cloud services[2]. A defining moment came in 2025, when Oracle secured a $300 billion, five-year agreement with OpenAI, along with major contracts with xAI and Meta, to deliver unprecedented cloud and AI infrastructure

Nvidia Corporation, founded in 1993 by Jensen Huang, Chris Malachowsky, and Curtis Priem and headquartered in Santa Clara, California, is a pioneering American technology company best known for inventing the graphics processing unit (GPU) in 1999[1][2][4]. Initially focused on GPUs for video gaming, Nvidia has expanded its scope to serve diverse markets, including artificial intelligence (AI), high-performance computing (HPC), professional visualization, automotive technology, and mobile devices[1][3]. Nvidia’s GPUs, such as the GeForce series for gamers and the RTX series for professional applications, are central to its dominance, controlling over 90% of the discrete GPU market as of early 2025[1][4]. The company’s investment in CUDA, a parallel computing platform and API launched in the early 2000s, revolutionized GPU computing by enabling GPUs to accelerate a wide range of compute-intensive tasks, particularly in AI and scientific research[1][4]. By 2025, Nvidia commanded over 80% of the GPU market for AI training and inference and supplied chips to more than 75% of the world’s top 500 supercomputers[1]. Nvidia’s influence extends beyond hardware. It offers a comprehensive ecosystem including software platforms like Omniverse for 3D simulation and digital twins, AI frameworks such as MONAI for medical imaging, and Jetson for robotics and edge AI[2][3]. Its technologies power autonomous vehicle data centers, AI factories, and cloud gaming services like GeForce Now[2][7]. Financially, Nvidia achieved record full-year revenue of $130.5 billion in fiscal 2025, with a workforce of over 36,000 employees worldwide and a robust patent portfolio exceeding 8,700 applications[2]. The company is recognized for innovation and workplace excellence, topping Forbes’ "America’s Best Companies 2025" and Fast Company’s "World’s Most Innovative Companies"

Kenvue Inc. is an American consumer health company that emerged as an independent entity after being spun off from Johnson & Johnson’s Consumer Healthcare division. It was officially named Kenvue in September 2022 and became fully independent in August 2023, marking a historic shift in the consumer health industry[1][2][3]. Headquartered in Skillman, New Jersey, with plans to relocate to Summit, New Jersey, Kenvue employs around 22,200 people as of 2022[1]. Kenvue owns a portfolio of iconic, trusted brands including Aveeno, Band-Aid, Benadryl, Johnson’s, Listerine, Neutrogena, Tylenol, and Zyrtec, serving approximately 1.2 billion people globally[1][4]. These brands have a heritage of over 135 years backed by extensive research and development, focusing on innovative, science-backed consumer health solutions[3][4]. The company's mission centers on delivering everyday care that improves health outcomes and enriches lives worldwide. The company’s spin-off was a significant business event, highlighted by its IPO in May 2023, which raised $3.8 billion and was the largest U.S. IPO since 2021, with an initial valuation of about $41 billion[1][5]. Initially, Johnson & Johnson retained over 90% ownership but completed full separation through a share exchange by July 2023, after which Kenvue was added to the S&P 500 Dividend Aristocrats index[1][2]. Kenvue’s leadership initially included CEO Thibaut Mongon until his termination in 2025, after which Kirk Perry took over as interim CEO[1]. The company has faced challenges, including a securities class action in 2023 over alleged misleading disclosures related to phenylephrine risks, affecting its stock performance[1]. Notably, the name "Kenvue" symbolizes a fusion of knowledg

The **Trump Administration** refers to the executive branch of the United States government under President Donald J. Trump, covering two non-consecutive periods: his first term from 2017 to 2021 and his second term beginning in 2025. As an organization, it is responsible for executing federal laws, shaping public policy, and managing national affairs during its tenure. During the **first Trump Administration (2017–2021)**, the administration pursued a wide-ranging agenda focused on immigration reform, economic nationalism, deregulation, judiciary appointments, and foreign policy shifts. Key actions included building and expanding the U.S.-Mexico border wall—completing 458 miles by January 2021—and implementing strict immigration policies such as travel bans from several predominantly Muslim countries and rescinding the DAPA amnesty program[2]. The administration withdrew the U.S. from the Trans-Pacific Partnership trade deal, renegotiated NAFTA into the USMCA, and signed the "Buy American and Hire American" executive order to prioritize American workers[1][3][5]. Judicially, Trump appointed three Supreme Court justices—Neil Gorsuch, Brett Kavanaugh, and Amy Coney Barrett—significantly influencing the federal judiciary with over 200 judicial appointments[5]. The administration also focused on military expansion, combating ISIS, addressing the opioid crisis, and responding to the COVID-19 pandemic with vaccine development support[5]. Foreign policy was marked by controversial decisions including troop withdrawals from northern Syria, reinforced support for Saudi Arabia, and tensions with Iran and North Korea[4]. The administration faced two impeachments: first in 2019 over Ukraine dealings and again in 2021 following the January Capitol riot; Trump was acquitted by the Senate both times[4][5]. After losing the 2020 election, Trump returned for a **second term starting in 2025**, continuing his policy priorities with new regulatory changes and political appointments[6][8]. The Trump Administration